Acute symptomatic angle closure needs immediate ophthalmic treatment. LPI addresses pupillary block; lens-related and secondary mechanisms need their own assessment.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Recognise and treat the acute emergency
Sudden painful red eye, blurred vision or haloes with headache, nausea or vomiting can indicate acute angle closure. A mid-dilated poorly reactive pupil, corneal oedema and a shallow peripheral anterior chamber support the diagnosis; obtain urgent ophthalmic assessment and begin treatment without delay. 1 2
Measure intraocular pressure (IOP) and confirm the angle mechanism. Pressure is often very high, but no single pressure threshold or fixed interval to irreversible damage defines safety; do not wait for a numerical cutoff or for several hours to pass. 1 2
Take a medication, allergy and systemic history while arranging urgent care. Topical aqueous suppressants, systemic acetazolamide when suitable, anti-inflammatory treatment, analgesia and antiemesis are selected under supervision; beta-blockers and alpha-agonists need their own contraindication checks. 1 2
Severe renal disease, relevant drug allergy and metabolic or electrolyte risks affect systemic treatment; mannitol requires cardiorenal and fluid assessment. 1 2
Pilocarpine is used for a pupillary-block mechanism, but may fail while the iris sphincter is ischaemic at very high IOP. EGS advises deferral at IOP ≥40 mmHg until pressure falls; this is a treatment-context threshold, not an emergency diagnostic rule. 1 2
Avoid intensive repeated dosing and do not use miotics for lens-induced or retrolenticular closure, where cycloplegia is used instead. 1 2
Laser peripheral iridotomy (LPI) relieves pupillary block by connecting the posterior and anterior chambers; it does not create a new trabecular outflow route. Perform it as soon as the cornea and patient permit. If medication does not break the attack or corneal oedema prevents LPI, specialist escalation may include iridoplasty, surgical iridectomy or cyclodiode according to the mechanism and response. 1 2
02Separate anatomical risk, closure and damage
Primary angle-closure suspect (PACS), primary angle closure (PAC) and primary angle-closure glaucoma (PACG) describe different clinical states. Iridotrabecular contact (ITC) means iris contact with the trabecular meshwork; peripheral anterior synechiae (PAS) are fixed adhesions. EGS uses ITC ≥180°, rather than the original strict >180° threshold. 1
Examine the optic disc, retinal nerve fibre layer (RNFL), optical coherence tomography (OCT) and reliable visual fields. PACG is defined by glaucomatous optic neuropathy; do not require every structural and field test to be abnormal simultaneously before recognising damage. Chronic closure can be asymptomatic, while an acute attack can occur before established glaucoma. 1
| Stage | Meaning | Diagnostic findings |
|---|---|---|
| PACS | Anatomical risk | ITC ≥180°; normal IOP; no PAS or glaucomatous optic neuropathy. |
| PAC | Closure without glaucoma | ITC ≥180° plus raised IOP and/or PAS; no glaucomatous optic neuropathy. |
| PACG | Glaucomatous disease | ITC ≥180° with glaucomatous optic neuropathy; assess the visual field and stage. |
03Identify the mechanism before choosing treatment
In pupillary block, resistance at the pupil creates a pressure difference and bows the peripheral iris forward (iris bombé). The peripheral chamber is shallower than the central chamber. Relieving this component does not reverse established PAS or guarantee normal long-term outflow. 1
Anterior ciliary processes can support a plateau-iris configuration with a relatively deep central chamber and crowded peripheral angle. The double-hump sign during indentation supports this mechanism; ultrasound biomicroscopy (UBM) can show the ciliary anatomy. 1
Plateau-iris syndrome describes persistent appositional closure after a patent iridotomy has removed pupillary block. 1
A thick, anteriorly positioned, intumescent or displaced lens can crowd the angle and shallow the chamber centrally and peripherally. Lens vault measures the anterior lens surface relative to the line joining the scleral spurs. Use the full anatomy and clinical state to decide on lens surgery; a single lens-vault measurement does not prove that LPI will fail. 1
Aqueous misdirection, also called malignant glaucoma, produces forward displacement of the iris–lens diaphragm and uniform chamber shallowing, often after surgery. Exclude pupillary block and choroidal causes. 1
Cycloplegia and aqueous suppression are initial options; miotics are contraindicated. A patent iridotomy must be present, but further treatment may require laser or surgery according to lens status. 1
In selected pseudophakic eyes, zonulo-hyaloido-vitrectomy (ZHV) creates communication through the zonules, anterior hyaloid and vitreous; this explains the teaching expression “unicameral eye”. It is not a universal first operation or a guarantee against recurrence. Phakic eyes may need a posterior approach with or without lens extraction. 1
04Use gonioscopy and imaging together
Static gonioscopy documents the extent of closure; indentation tests whether the angle opens. Apposition can open with indentation, whereas established PAS remain adherent. Interpret mixed areas together rather than assigning an entire eye to a single sign. 1
Anterior-segment OCT (AS-OCT) documents angle width and lens vault without contact, but does not replace dynamic gonioscopy or reliably identify every PAS. UBM is particularly helpful for plateau iris, lens position and posterior pushing mechanisms. Use central and peripheral chamber depth as clues, then verify the cause. 1
The original terms “Volcano Sign” and “So-was-Effekt” are retained in the terminology record, but an authoritative definition and diagnostic performance remain unresolved. Describe the observed iris–lens anatomy directly. A named sign or a lens-vault cutoff should not substitute for mechanism-based assessment. 1
05Discuss prevention in PACS with absolute risk
ZAP randomised one eye of each of 889 community-screened Chinese participants aged 50–70 years with bilateral PACS to LPI; the fellow eye was untreated. 6
At 6 years, composite closure events occurred in 19 treated versus 36 control eyes; rates were 4.19 versus 7.97 per 1000 eye-years, HR 0.53 (95% CI 0.30–0.92). The endpoint combined pressure elevation, PAS or an acute attack, rather than visual loss. 6
The 14-year extension reported 33 versus 105 composite events, HR 0.31 (95% CI 0.21–0.46); acute attacks occurred in 1 versus 5 eyes and PACG in 2 versus 4. 7 8
However, 390 treated and 388 control eyes were lost to follow-up. The published correction changes a baseline depth predictor, without changing the reported overall results and conclusions. Rare sight-threatening outcomes and attrition still limit certainty about long-term visual benefit. 7 8
ANA-LIS enrolled 480 clinic patients over 50 years with bilateral asymptomatic PACS. At 5 years, the composite endpoint occurred in 24 LPI eyes (5.0%) versus 45 control eyes (9.4%); adjusted HR 0.55 (95% CI 0.37–0.83), NNT 22 (95% CI 12.8–57.5). 9
This paired-eye trial supports reduced PAC/PACG endpoints, but its clinic population and endpoint definitions differ from ZAP; do not pool the percentages as an individual prognosis. 9
Observation with regular review is reasonable for many low-risk PACS eyes; prophylactic LPI is considered when additional risk makes the balance more favourable. Examples include necessary repeated dilation, marked hypermetropia, relevant family history, inability to report symptoms or remote access to emergency care. Diabetes matters when it creates a need for retinal examination and dilation, not as an automatic LPI indication by itself. 1 2
06Choose lens treatment for the relevant population
EAGLE randomised 419 participants aged ≥50 years without cataract to clear-lens extraction or standard LPI with medication as needed. Eligibility was newly diagnosed PAC with IOP ≥30 mmHg or PACG; advanced glaucoma and previous acute attacks were excluded. 4 5
At 36 months, extraction improved health-status score by 0.052 (95% CI 0.015–0.088) and lowered IOP by 1.18 mmHg (95% CI 0.38–1.99) relative to standard care. 4 5
This was an unmasked treatment comparison, with complete health-status data for 351 participants and IOP data for 366. The modest mean pressure difference and patient-reported benefit must be weighed against surgery, loss of accommodation and the individual target pressure. The trial does not justify clear-lens extraction for all PACS or claim that lens surgery alone cures every PACG eye. 4 5
Symptomatic cataract and lens crowding favour lens extraction, but timing follows pressure control, corneal clarity, inflammation and surgical risk. RCOphth discusses early surgery approximately 1–4 weeks after presentation in cataract-associated acute closure; EGS stresses operating when the eye is quiet. This is not a mandatory waiting interval or a universal schedule for every mechanism. 1 2
After an acute attack, shallow chamber, endothelial injury, poor dilation and zonular weakness can complicate phacoemulsification. Lens extraction widens the angle but may not restore damaged trabecular function or undo PAS. The original percentage hierarchy for acute closure, chronic PACG, pseudoexfoliation and POAG lacks a verified common comparison; do not use it as a prediction or ranking. 1
07Assess additional surgery without a blanket MIGS rule
Goniosynechialysis (GSL) mechanically separates PAS, but anatomical opening need not add pressure benefit to phaco alone. 10
In a randomised trial of 78 cataract/PAC or PACG eyes with ≥90° PAS, success at 1 year was 52.5% with phaco alone versus 57.9% with phaco-GSL; difference 5.4% (95% CI −18.0 to 28.2), p=0.63. The wide interval and short follow-up do not prove equivalence or rule out benefit in every subgroup. 10
Gonioscopy-assisted transluminal trabeculotomy (GATT), Kahook Dual Blade (KDB) and OMNI act on different parts of the conventional outflow pathway and require suitable angle access. Mean deviation (MD) alone is not an indication. In advanced or progressing disease with a low target pressure, consider whether a trabecular procedure can realistically achieve it; filtering surgery or another approach may be needed. 1 12
The original “Bank-Technik” remains an unresolved source term for manual goniotomy; it is not silently renamed BANG. A separate 2026 BANG–GATT trial studied mild/moderate pseudophakic POAG, explicitly excluding angle closure, and used a 23G bent needle for a 90° BANG procedure. 12
It does not verify the original 25–30G/90–120° recipe, KDB/OMNI equivalence or a cost advantage in PACG. 12
08Review secondary causes and prevent recurrence
Topiramate can cause supraciliary effusion with forward movement of the iris–lens diaphragm, often bilateral closure and an acute myopic shift. Seek urgent specialist care and coordinate rapid withdrawal with the prescriber, particularly in epilepsy. Use mechanism-directed pressure control, cycloplegia and anti-inflammatory treatment; miotics can worsen this non-pupillary mechanism, and LPI does not correct the effusion itself. 1 2 11
Uveitis, posterior synechiae with iris bombé, neovascular membranes, lens displacement and other posterior pushing causes need cause-specific care. A treatment that helps pupillary block may worsen another mechanism. Do not apply a single acute-primary algorithm to all secondary angle closure. 1 2
After the attack, reassess gonioscopy, iridotomy patency, IOP, PAS, optic nerve and visual field, then set follow-up and target pressure. The phakic fellow eye with the same anatomical risk generally needs prompt prophylactic LPI, ideally during the acute-care episode or before discharge. 1 2
Existing lens extraction, a patent iridotomy and a secondary mechanism change that decision; unilateral drug-related closure does not prove identical pupillary-block risk in the fellow eye. 1 2
Use the angle-closure guideline that actually addresses the mechanism and setting. The official DOG/BVA list labels 15a as POAG/NTG/OHT and 15b as childhood glaucoma; 15a excludes angle closure. It therefore cannot support the original attribution of a complete German acute-angle-closure algorithm or a medicolegal verdict about a missed test. 1 2 3
| Topic | Finding / mechanism | Evidence / next step | Imaging / examination | Caution |
|---|---|---|---|---|
| PACS | ITC ≥180°, normal IOP | Observe or select LPI by added risk; ZAP/ANA-LIS | Gonioscopy; AS-OCT supplementary | Diabetes/travel alone is not a universal indication. |
| PAC/PACG | Raised IOP/PAS; glaucoma distinguishes PACG | EAGLE supports selected lens extraction | Gonioscopy, RNFL/OCT and field | Consider age, accommodation and target pressure. |
| Acute attack | Pain, oedema, closed angle, often high IOP | Immediate pressure control; LPI for pupillary block | Slit lamp, tonometry, gonioscopy | Assess the fellow eye; no safe waiting period. |
| Plateau iris | Anterior ciliary processes; peripheral crowding | Relieve coexisting pupillary block; reassess after LPI | Double-hump sign; UBM anatomy | Patent LPI does not exclude persistent closure. |
| Lens-related | Lens crowding; central and peripheral shallowing | Consider lens surgery by clinical state | AS-OCT lens vault; UBM if needed | No verified universal vault cutoff for LPI failure. |
| Malignant glaucoma | Aqueous misdirection; uniform shallowing | Cycloplegia; selected laser or ZHV / vitrectomy | Exclude pupillary block and choroidal causes | No miotics; treatment depends on lens status. |
| Secondary closure | Uveitis, membranes, topiramate effusion | Treat cause and mechanism | UBM for effusion / posterior pushing | Topiramate: coordinate withdrawal; avoid miotics. |
What are the main learning points?
Acute symptomatic angle closure needs immediate ophthalmic treatment. LPI addresses pupillary block; lens-related and secondary mechanisms need their own assessment.
When is assessment urgent?
Sudden severe eye pain, red eye, blurred vision or haloes with nausea/vomiting require immediate eye-emergency care. Do not wait for all symptoms, press on the eye to test its hardness, or delay care to try eye drops.
References and access status
- 1EGS 6th edition, 2025 — angle closure / aqueous misdirection
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Selected text read: mechanisms, classification, diagnosis, PACS/PAC/PACG, acute care, post-acute surgery and aqueous misdirection, printed pp138–149/153. Not the complete guideline or every source trial.
- 2RCOphth — Management of Angle-Closure Glaucoma, June 2022
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Official PDF retrieved; cover and selected acute-care text/pathway, printed pp20–24, read as extraction. Evidence search December2020; review due June2025. The2026 hosting path is not a new edition; no full-guideline or pixel inspection claimed.
- 3DOG/BVA — official guideline list and scope of15a
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Official list and 15a first-page scope inspected.15a concerns POAG/NTG/OHT (2006) and excludes angle closure;15b concerns childhood glaucoma (1998). No applicable current German acute algorithm verified.
- 4Azuara-Blanco et al. — EAGLE, Lancet2016; PMID27707497
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Complete primary abstract read; main report, protocol and supplements not read. Abstract subgroup counts do not sum to the stated total; no silent reconciliation.
- 5Mitchell et al. — EAGLE secondary analysis, BJO2023
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Selected primary methods and eligibility text read, including advanced-glaucoma and prior-acute-attack exclusions. Not the full analysis or supplements.
- 6He et al. — ZAP6-year RCT, Lancet2019; PMID30878226
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Complete primary abstract and indexed selected design/results passages read; main tables, protocol and supplements not fully read.
- 7Yuan et al. — ZAP14-year extension, Ophthalmology2023; PMID37030454
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Complete indexed primary abstract and selected primary results/table extractions inspected; linked indexed correction now read. Not complete report, figures or supplements.
- 8ZAP14-year corrigendum, Ophthalmology2024; PMID38128972
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Complete indexed correction notice inspected: the abstract predictor is shallower, not greater, central anterior chamber depth. The notice states that overall results and conclusions are unchanged. Direct page retrieval returned403; no PDF/pixel inspection claimed.
- 9Baskaran et al. — ANA-LIS5-year RCT; PMID34453952
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Complete indexed primary abstract read. Full report, tables, protocol and supplements not read.
- 10Husain et al. — phaco ± GSL RCT, JAMA Ophthalmology2019; PMID31294768
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Complete primary abstract read. Full report, protocol and supplements not read; absence of significant difference is not equivalence.
- 11DailyMed — topiramate label, section5.1
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Current hosted US label section5.1 (version20260128) read. Not a German product label or the full prescribing information; withdrawal requires treating-team judgement.
- 12Ayub/Costa — BANG vs GATT24-month RCT, Eye2026
Historical 013-angle-closure-glaucoma appraisal reused; not new full-source access. Primary abstract and selected methods/eligibility/procedure/results passages read. Small POAG study excludes angle closure. Original Bank identity remains unresolved; full supplements not read. Earlier review 004 records an abstract/body success-rate discrepancy.
- 13Immutable original export; own primary/secondary angle-closure lecture; recording unchecked
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
Original lecture link
For patients
In angle closure, the iris blocks drainage inside the eye. It can occur suddenly with pain or develop quietly; glaucoma means that the optic nerve is damaged.
After an attack, both eyes need assessment. Treatment of the other eye depends on its anatomy and previous treatment; regular checks remain necessary after laser or surgery.
Bring a list of prescription and non-prescription medicines. Some medicines can trigger closure in susceptible eyes; discuss changes with the treating team and do not attempt treatment with borrowed eye drops.
Sudden severe eye pain, red eye, blurred vision or haloes with nausea/vomiting require immediate eye-emergency care. Do not wait for all symptoms, press on the eye to test its hardness, or delay care to try eye drops.